PATENT CLAIM ANALYSIS

Application Number: 15759177
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["544", "279000"]

Abstract:
Provided are methods, uses, pharmaceutical regimens, pharmaceutical compositions, and kits comprising modulators of TLR8 and pharmaceutically acceptable salts thereof, useful in treating HIV infections.

Claim (Index 33):
The pharmaceutical composition of  claims 26 - 27 , wherein the TLR8 modulating compound is selected from the group consisting of: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 90.0
- Lexical Diversity: 1.25
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14998042', '15692093', '15885390', '14836774', '14998131']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7936818862533317
- 35 USC 102 Novelty (BERT): 0.5277210154316789
- Combined Prediction Score: 0.7670857991711665
- Mean Citation Score: 328.595098
- Max Citation Score: 344.2271
- Similarity Product: 252.9671194082141

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test